Anthony Bishop is a regular TBD supporter who has worked in Australia Singapore and Malaysia on global development programs. He is involved in politics to pursue permanency for children in Queensland child safety system.
His professional career is in drug development and in the unlikely event the discussion runs short on child safety, Anthony is happy to field questions on what has been going on in drug development and approvals during Covid.
Anthony has more than 25 years of experience in the commercial and operational elements of pharmaceutical development. Beginning at CSL as a production Scientist, Anthony progressed to Project Management Roles. On moving to Singapore, he project managed the first Asian central lab before moving to a business development role at Quintiles (now IQVIA) before leading the development of a new antibiotic through Phase 1 for Merlion Pharma. He helped found a biotech which went on to attract venture capital and moved to Malaysia to run the company. After 16 years in Asia, Anthony returned to Australia into a business development role with Quintiles before leading the development of a biologic for Factor Therapeutics through Phase 2 and then a whole genome diagnostic at genomiQa. His experience covers all aspects of global drug development and commercialisation from both the sponsor and CRO sides of the business.
Anthony has a Bachelor of Applied Science, Medical Laboratory Science from QUT and a Graduate Diploma of Manufacturing Management from RMIT.
